Genomic Health, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Exact Sciences Is Going Higher
Article By: Quad 7 Capital
Tuesday, July 30, 2019 12:23 PM EDT
With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.
In this article: EXAS, GHDX Also: PFE
Triple Play Acquiring Triple Play
Article By: Bespoke Investment Group
Monday, July 29, 2019 1:14 PM EDT
Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.
In this article: GHDX, EXAS
Exact Sciences Will Acquire Genomic Health In $2.8B Deal
Article By: Benzinga
Monday, July 29, 2019 9:37 AM EDT
Exact Sciences Corp. will acquire Genomic Health, Inc. for $72 per share in a cash and stock transaction valued at $2.8 billion.
In this article: GHDX, EXAS
4 Small Biotech Stocks Likely To Witness More Upside In 2019
Article By: Zacks Investment Research
Saturday, March 30, 2019 5:45 AM EDT
Here are four companies from the biotech/drug sector which have performed well so far in 2019 and still hold upside. All these stocks have seen their share price and earnings estimates rise this year.
In this article: ANIP, KMDA, GHDX, NLNK Also: VRTX, BIIB, AMGN
Genomic Health Is Positioned For Strong Returns
Article By: Andres Cardenal
Tuesday, January 1, 2019 7:13 AM EDT
Genomic Health is delivering solid results and benefiting from accelerating adoption, reimbursement, and revenue growth.
In this article: GHDX Also: ILMN, EDIT, CRSP

Latest Tweets for $GHDX

No tweets yet!